The phone numbers for more information about the studies below are 1-866-444-2214 (TTY 1-866-411-1010) unless otherwise noted.
Severe Asthma Study for Adults, 18-75
You may be eligible to participate in a clinical research study with the medication Actos. The goal of the study is to determine if Actos is effective for treating severe asthma. The study will last 48 weeks and there are a total of 15 visits required. In order to participate, you must have a diagnosis of severe asthma for at least 1 year, have not smoked cigarettes within the past year and do not have a history of emphysema or sarcoidosis. Travel assistance may be provided consistent with NIH guidelines. Refer to study 09-H-0244.
Seeking Patients with Physical Induced Hives
Do you or someone you know develop hives when coming into contact with cold, heat, pressure or other exposures? This could signal physical urticaria. If you or a family member are between the ages of 6 months and 65 years old and a physician has diagnosed this condition, the patient may be eligible to participate in a study with the National Institute of Allergy and Infectious Diseases. The study will explore the body’s role in the inflammatory response that causes hives. Participants will be required to travel to NIH and a short overnight stay may be required. Refer to study 09-I-0126. Se habla español.
Loa Loa Study
Have you ever traveled to or lived in central or western Africa for longer than 1 month? Have you or someone you know experienced worms moving along the white part of the eye? Are you between 18 and 65 years old? NIAID is seeking volunteers to participate in a research study evaluating the effectiveness of reslizumab in reducing the side effects of the standard drug therapy used to treat Loa loa. All participants will be required to travel to NIH for an overnight stay. All study-related tests or treatment are provided at no cost. Refer to study 10-I-0101. Se habla español.
Volunteers are needed for a study examining immune function in healthy volunteers given short-term treatment of sitagliptin (brand name Januvia). Investigators wish to determine if and how sitagliptin alters immune function. If you are 18 years or older and healthy, consider participating in this study. All study-related tests are provided at no cost. Compensation is provided. Refer to study 09-DK-0055.
Hepatitis B Study
Did you receive the hepatitis B vaccine or did you recover from acute hepatitis B more than 10 years ago? Would you like to know if you still have protective antibody levels? Consider participating in the Hepatitis B Vaccine Immunity Study. This study consists of one outpatient clinic visit for a blood draw and a short research questionnaire. Participants must have been 18 years of age or older and younger than age 60 when the hepatitis B vaccine was administered. The vaccine must have been given prior to the year 2000. Individuals who have a history of chronic HBV infection or those who did not receive all 3 doses of HBV vaccine are not eligible for participation. For more information, call (301) 435-6121. Refer to study 10-DK-0187. Compensation is provided.